IDEX IDEX BIOMETRICS ASA

Mandatory disclosure of holding and notice of trade in IDEX Biometrics - 1 August 2025

Mandatory disclosure of holding and notice of trade in IDEX Biometrics - 1 August 2025

Reference is made to IDEX Biometrics ASA's disclosure on 21 July 2025 of a private placement of 9,090,909 shares at NOK 3.30 per share. IDEX discloses the following information on behalf of a major shareholder and primary insider.

Tranche 1 of the private placement amounted to 4,731,594 shares. All shares was lent, not sold, by CEO and CFO Anders Storbråten.

The shares – 4,731,594 – is now returned to Anders Storbråten. Storbråten and close relations hold 11,235,070 shares or 21,57 % shares of the total outstanding shares and votes in IDEX Biometrics after completion of Tranche 1.

IDEX Biometrics’ reports and presentations are available on our website:

For further information, please contact: Anders Storbråten, CEO and CFO, Tel: +47 416 38 582

E-mail: 

About IDEX Biometrics:

IDEX Biometrics ASA (IDEX) is a global technology leader in fingerprint biometrics, offering authentication solutions across payments, access control, and digital identity. Our solutions bring convenience, security, peace of mind and seamless user experiences to the world. Built on patented and proprietary sensor technologies, integrated circuit designs, and software, our biometric solutions target card-based applications for payments and digital authentication. As an industry-enabler we partner with leading card manufacturers and technology companies to bring our solutions to market.

For more information, visit

About this notice:

This notice was issued by Kjell-Arne Besseberg, COO, on 1 August 2025 at 18:00 CEST on behalf of IDEX Biometrics ASA. The information about the lending shall be disclosed according to article 19 no. 3 of the EU Market Abuse Regulation (EU 596/2014). The information about shareholding shall be disclosed according to section 4-2 of the Norwegian Securities Trading Act (STA). The information is published in accordance with section 5-12 of the Norwegian Securities Trading Act.



EN
01/08/2025

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on IDEX BIOMETRICS ASA

 PRESS RELEASE

Mandatory notice of shareholding 22 August 2025

Mandatory notice of shareholding 22 August 2025 Reference is made to IDEX Biometrics ASA’s disclosure on 21 July 2025 of a private placement of 9,090,909 shares at NOK 3.30 per share. The Tranche 2 shares subscription andallocation have been completed on 20 August 2025. Altea AS will hold 5,347,321 shares in IDEX. The ownership will represent 10,26% of the shares and voting rights in IDEX. About this notice: The information shall be disclosed according to section 4-2 of the Norwegian Securities Trading Act (STA) and published in accordance with section 5-12 of the STA.

 PRESS RELEASE

Registration of share capital increase in IDEX Biometrics 22 August 20...

Registration of share capital increase in IDEX Biometrics 22 August 2025 Reference is made to IDEX Biometrics ASA's disclosure on 21 July 2025 of a private placement of 9,090,909 shares at NOK 3.30 per share, split in two tranches. The share capital increase related to the Tranche 2 and underwriting shares have been registered and the shares will be delivered soonest. The Tranche 2 ander underwriting shares will be delivered on a separate and non-tradable ISIN, pending publication by the Company of aprospectus approved by the Norwegian Financial Supervisory Authority. Following the issue...

 PRESS RELEASE

Mandatory disclosure of holding and notice of trade in IDEX Biometrics...

Mandatory disclosure of holding and notice of trade in IDEX Biometrics – 15 August 2025 Reference is made to IDEX Biometrics ASA’s disclosure on 21 July 2025 of a private placement of 9,090,909 shares at NOK 3.30 per share. IDEX discloses the following information on behalf of a major shareholder and primary insider. In connection with the private placement, the manager of the private placement, IDEX Biometrics and Mr. Storbråten entered into a share lending agreement. Mr. Storbråten has lent 4,359,315 shares, in connection with the settlement of Tranche 2. The shares have been lent, not...

 PRESS RELEASE

IDEX Biometrics ASA: Extraordinary general meeting held on 14 August 2...

IDEX Biometrics ASA: Extraordinary general meeting held on 14 August 2025 IDEX Biometrics ASA held an extraordinary general meeting on 14 August 2025.All resolutions were passed as proposed in the notice and agenda update for the meeting.The minutes of the meeting will be available at the company's web site in due course. IDEX Biometrics’ reports and presentations are available on our website:  For further information, please contact: Anders Storbråten, CEO and CFO, Tel: +47 416 38 582 E-mail:  About IDEX Biometrics: IDEX Biometrics ASA (IDEX) is a global technology leader in fingerpri...

 PRESS RELEASE

Mandatory disclosure of holding and notice of trade in IDEX Biometrics...

Mandatory disclosure of holding and notice of trade in IDEX Biometrics - 1 August 2025 Reference is made to IDEX Biometrics ASA's disclosure on 21 July 2025 of a private placement of 9,090,909 shares at NOK 3.30 per share. IDEX discloses the following information on behalf of a major shareholder and primary insider. Tranche 1 of the private placement amounted to 4,731,594 shares. All shares was lent, not sold, by CEO and CFO Anders Storbråten. The shares – 4,731,594 – is now returned to Anders Storbråten. Storbråten and close relations hold 11,235,070 shares or 21,57 % shares of the total...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch